We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$460M
AUM Growth
+$84.2M
Cap. Flow
+$106M
Cap. Flow %
23.1%
Top 10 Hldgs %
34.98%
Holding
99
New
18
Increased
56
Reduced
8
Closed
16

Top Buys

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$14.6M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$10.6M
3
BDX icon
Becton Dickinson
BDX
+$9.74M
4
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$9.13M
5
ZBH icon
Zimmer Biomet
ZBH
+$8.16M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$14.7M
2
CNCE
Concert Pharmaceuticals, Inc.
CNCE
+$7.03M
3
DHR icon
Danaher
DHR
+$5.95M
4
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$4.6M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$4.58M

Sector Composition

Rank Sector Weight
1 Healthcare 99.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$23.1B
$24.2M 5.26%
108,072
+7,370
+7% +$1.82M
NBIX icon
2
Neurocrine Biosciences
NBIX
$16.6B
$22M 4.8%
217,838
+101,505
+87% +$10.6M
BSX icon
3
Boston Scientific
BSX
$71.5B
$21.4M 4.66%
428,231
+60,298
+16% +$2.84M
COO icon
4
Cooper Companies
COO
$14.5B
$19.6M 4.25%
209,536
+169,536
+424% +$14.6M
LNTH icon
5
Lantheus
LNTH
$6.59B
$15.5M 3.36%
187,187
+96,264
+106% +$6.21M
SGEN
6
DELISTED
Seagen Inc. Common Stock
SGEN
$14.8M 3.22%
73,100
-8,754
-11% -$1.4M
HAE icon
7
Haemonetics
HAE
$4B
$11.6M 2.53%
140,740
+8,362
+6% +$677K
THC icon
8
Tenet Healthcare
THC
$21.1B
$11M 2.4%
185,832
+59,327
+47% +$3.3M
SDGR icon
9
Schrodinger
SDGR
$1.36B
$10.5M 2.29%
399,170
+171,219
+75% +$4.07M
SWAV
10
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$10.2M 2.21%
+46,855
New +$9.13M
ELV icon
11
Elevance Health
ELV
$85.5B
$9.95M 2.16%
21,643
+9,347
+76% +$4.45M
XENE icon
12
Xenon Pharmaceuticals
XENE
$6.12B
$9.92M 2.16%
277,283
+41,792
+18% +$1.54M
BDX icon
13
Becton Dickinson
BDX
$48.2B
$9.85M 2.14%
+39,788
New +$9.74M
VRNA
14
DELISTED
Verona Pharma
VRNA
$9.8M 2.13%
487,995
+73,547
+18% +$1.59M
LLY icon
15
Eli Lilly
LLY
$1.06T
$9.5M 2.07%
27,671
-6,767
-20% -$2.28M
SILK
16
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$9.39M 2.04%
239,864
+146,559
+157% +$7.17M
DXCM icon
17
DexCom
DXCM
$32B
$9.17M 1.99%
78,927
+16,197
+26% +$1.81M
PODD icon
18
Insulet
PODD
$9.79B
$9.17M 1.99%
28,744
+10,702
+59% +$3.17M
IQV icon
19
IQVIA
IQV
$39.3B
$9.08M 1.97%
45,643
+30,269
+197% +$6.47M
HUM icon
20
Humana
HUM
$46.2B
$8.66M 1.88%
17,837
+398
+2% +$197K
CDMO
21
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$8.52M 1.85%
453,952
+25,684
+6% +$422K
ZBH icon
22
Zimmer Biomet
ZBH
$18.4B
$8.4M 1.83%
+65,000
New +$8.16M
KROS icon
23
Keros Therapeutics
KROS
$221M
$7.66M 1.67%
179,290
+52,500
+41% +$2.65M
DCPH
24
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$7.6M 1.65%
491,772
+146,852
+43% +$2.45M
CTIC
25
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$7.37M 1.6%
1,753,630
+344,988
+24% +$1.79M
1
2 3 4

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
SFO
Stokes Family Office New Orleans, Louisiana $969M AUM 19.6% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return

Parkman Healthcare Partners's Q1 2023 Portfolio in Review

As of Q1 2023, Parkman Healthcare Partners held 99 positions worth $460M, up 22% from $376M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parkman Healthcare Partners deployed $106M of net new capital in Q1 2023, opening 18 new positions and adding to 56 existing holdings. Its largest new stake was Becton Dickinson: 39,788 shares worth $9.85M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 98% a quarter earlier.

On the sell side, the largest reduction was Danaher, an estimated $5.95M trimmed.

  • Parkman Healthcare Partners's largest Q1 2023 buy was Becton Dickinson: 39,788 shares worth $9.85M.
  • Parkman Healthcare Partners added most to Cooper Companies in Q1 2023, an estimated $14.6M increase.
  • Parkman Healthcare Partners's biggest Q1 2023 reduction was Danaher, cutting an estimated $5.95M.
  • Parkman Healthcare Partners fully exited UnitedHealth in Q1 2023, selling an estimated $14.7M.
  • Parkman Healthcare Partners's ten largest holdings make up 35% of its $460M portfolio in Q1 2023.
  • Parkman Healthcare Partners opened 18 new positions and closed 16 in Q1 2023.
  • Parkman Healthcare Partners's portfolio value rose 22% quarter-over-quarter to $460M.

Based on Parkman Healthcare Partners's 13F filing for Q1 2023, filed 12 May 2023.